✦ LIBER ✦

Epirubicin + docetaxel neoadjuvant chemo highly active against breast cancer

Book ID: 120849416
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2007
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200715720-00031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel in Combination with Epirubicin

Docetaxel in Combination with Epirubicin as Neoadjuvant Therapy in Operable Breast Cancer

📂 Article 📅 2000 🏛 CIG Media Group, LP. 🌐 English ⚖ 104 KB

Docetaxel and high-dose epirubicin as ne

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

✍ E. Espinosa; S. Morales; P. Borrega; A. Casas; C. Madroñal; I. Machengs; J. A. I 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 208 KB

Neoadjuvant Dose-Dense Gemcitabine plus

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer

✍ Dr Jacques Medioni, Cyrille Huchon, Marie-Aude Le Frere-Belda… 📂 Article 📅 2011 🏛 Adis International Limited (now part of Wolters Kl 🌐 English ⚖ 178 KB

Neoadjuvant docetaxel, vinorelbine and t

Neoadjuvant docetaxel, vinorelbine and trastuzumab active in HER-2 breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Phase II Trial of Neoadjuvant Chemothera

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

✍ Bhuvaneswari Ramaswamy; Steven P Povoski; Chris Rhoades; Joan Allen; Marsha Haug 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 227 KB

Influence of Neoadjuvant Therapy with Ep

Influence of Neoadjuvant Therapy with Epirubicin and Docetaxel on the Expression of HER2/neuin Patients with Breast Cancer

✍ Susanne Taucher; Margaretha Rudas; Robert M. Mader; Michael Gnant; Emanuel Sporn 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 83 KB